Michael Overdahl, MD
Pulmonary Disease Physician in Fort Wayne, Indiana. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Michael Overdahl, MD reported a CMS MIPS final score of 81.2/100 — below the 83.1 national average — and filed 2,036 Medicare Part D claims in 2023.
- 81.2/100
- MIPS score · -2 vs avg
- 2K
- Part D claims, 2023
- 32%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
Michael Overdahl, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
81 36th percentile higher than 36% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Overdahl, MD sits
This provider among pulmonary disease physician peers
Across the 2,676 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Overdahl, MD writes more Part D claims than 71% of them and scores higher on MIPS quality than 41% — placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Michael Overdahl, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Michael Overdahl, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Overdahl, MD?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Pulmonary Disease Physician compares to other specialties among Indiana providers
Largest specialties in Indiana (% of in-state providers)
Pulmonary Disease Physician ranks #82 among Indiana's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Indiana provider total, by primary NUCC taxonomy. The highlighted bar is Pulmonary Disease Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance — MIPS
Michael Overdahl, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 81.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pulmonary Disease Physician) — 81.2/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Pulmonary Disease Physician US NPIs
81.2/100 MIPS final score — 1.9 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pulmonary Disease Physician. Quality dim: 69. Cost dim: 68.5.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Overdahl, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 11104 PARKVIEW CIRCLE DR, Fort Wayne, IN, 46845, with a listed phone of (260) 266-5260. NPI 1316990112 was issued on 05/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Overdahl most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,036 prescription claims written by this provider, covering 395 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 68% brand-name and 32% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.2/100 for the 2023 performance year (Quality 69, Cost 68.5), compared with the national average of 83.1.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1316990112 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/19/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Michael Overdahl, MD's current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Michael Overdahl, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Overdahl, MD. Source: openpaymentsdata.cms.gov.
Total received
$32
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
68% brand-name claims vs 32% generic, on 2,036 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,932
- Total Day Supply
- 80,993
- Brand vs Generic
- 68% brand / 32% generic
- Brand Drug Cost
- $1.0M
- Generic Drug Cost
- $133K
- Antibiotic Claims
- 72
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 1.70
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 59, 65-74: 156, 75-84: 138, 85+: 42
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Overdahl, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trelegy Ellipta
Trelegy Ellipta
375 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
325 claims
- Breo Ellipta
Breo Ellipta
287 claims
- Azelastine Hcl 136
Azelastine Hcl
136 claims
- Montelukast Sodium 110
Montelukast Sodium
110 claims
- Methylprednisolone 97
Methylprednisolone
97 claims
- Symbicort 95
Symbicort
95 claims
- Prednisone 56
Prednisone
56 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 375 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 325 |
| Breo Ellipta Fluticasone/Vilanterol | 287 |
| Azelastine Hcl | 136 |
| Montelukast Sodium | 110 |
| Methylprednisolone | 97 |
| Symbicort Budesonide/Formoterol Fumarate | 95 |
| Prednisone | 56 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 52 |
| Spiriva Handihaler Tiotropium Bromide | 38 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Michael Overdahl, MD fits within the Pulmonary Disease Physician landscape nationally.
Michael Overdahl, MD's 2,036 claims are above the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Overdahl.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Indiana medical board — federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is Michael Overdahl, MD's specialty? ▼
How much does Michael Overdahl, MD prescribe under Medicare Part D? ▼
What is Michael Overdahl, MD's Medicare quality score? ▼
Where is Michael Overdahl, MD located? ▼
What is Michael Overdahl, MD's NPI number? ▼
Does Michael Overdahl, MD prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does Michael Overdahl, MD prescribe most often? ▼
Does Michael Overdahl, MD accept Medicare? ▼
How can I verify Michael Overdahl, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology